Skip to main content

Events

Featured Events

  • -

    APIC25

    Phoenix, Arizona | Americas
    Molecular diagnostics
    Find out more
    Add to Calendar
    Add to Calendar 2025-06-16T00:01:00 2025-06-18T23:59:59 APIC25 <p>Join us for an enlightening session addressing the critical importance of early and accurate identification of <em>Candida auris</em> (<em>C. auris</em>). This pathogen has emerged as a global health concern and poses a significant threat to vulnerable patients. Delayed detection can lead to dangerous outbreaks in healthcare settings.</p><p><strong>When:</strong> Tuesday, June 17, 2025</p><p><strong>Time:</strong> 12:45–1:15 p.m.</p><p><strong>Location:&nbsp;</strong>Exhibitor Theater - Booth #1937</p><p><strong>Speaker:&nbsp;</strong>Sarah Elliott, PhD, Principal Scientist, Scientific Affairs</p><p>&nbsp;</p><p><strong>Protecting Patients: Molecular Detection of </strong><em><strong>Candida auris</strong></em><strong> Colonization using the Simplexa<sup>®</sup> </strong><em><strong>C. auris</strong></em><strong> Direct assay</strong></p><p>Dr. Elliott will discuss the novel Simplexa<sup>®</sup> <em>C. auris</em> Direct assay—the first FDA De Novo granted molecular diagnostic test designed for the rapid and reliable detection of <em>C. auris</em> in patients suspected of colonization. Discover how this test can support your infection control strategies, safeguard patient health, and help prevent potentially deadly outbreaks.</p><p>Don't miss this opportunity to learn how Simplexa<sup>®</sup> <em>C. auris</em> Direct can play a pivotal role in combating the spread of <em>C. auris </em>and protecting our communities. &nbsp;</p> Phoenix, Arizona Diasorin diasorin@nomail.com UTC public
  • Booth 1201
    -

    ASM Microbe 2025

    Los Angeles, CA | Americas
    Immunodiagnostics
    Molecular diagnostics
    Find out more
    Add to Calendar
    Add to Calendar 2025-06-19T09:00:00 2025-06-22T16:00:00 ASM Microbe 2025 <p><span class="reply__text"><strong>Rapidly Ruling Out Bacterial Infection in the Emergency Departments of a Tertiary Cancer Center: The LIAISON<sup>®</sup> MeMed BV<sup>®</sup> Test</strong></span></p><p>We are pleased to welcome Dr. David M. Engman, Chairman Emeritus of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, who will provide an overview of a novel diagnostic assay designed to distinguish bacterial from viral infections and identify co-infections. Also welcome Krupa Jani, an ASCP-certified Clinical Laboratory Technologist and current Research Technologist in Clinical Microbiology Services at Memorial Sloan Kettering Cancer Center. She will share insights on the performance of the LIAISON<sup>®</sup> MeMed BV<sup>®</sup> test in cancer patients. This session will offer valuable perspectives on the application of advanced diagnostics in high-acuity clinical environments. We look forward to seeing you there.</p><p><strong>When:</strong> Thursday, June 19, 2025</p><p><strong>Time:</strong> 1:00–1:45 p.m.</p><p><strong>Location: </strong>Room 404 A/B,<strong> </strong><span class="reply__text">Los Angeles Convention Center, 1201 S Figueroa Street, Los Angeles, CA</span></p><p><strong>Speakers: </strong>David M. Engman, MD, PhD<br>Chairman Emeritus, Department of Pathology and Laboratory Medicine at Cedars Sinai Medical Center, <span class="reply__text">Los Angeles, CA</span></p><p>Krupa Jani, MS, ASCP (iMB)<br>Research Technologist, Clinical Microbiology Services at Memorial Sloan Kettering Cancer Center, New York, NY</p><p>&nbsp;</p><p><strong>Blueprint for Customizable Syndromic Testing: The Clinical and Economic Benefit of </strong><em><strong>Flex</strong></em><strong>™ Testing on Diasorin’s LIAISON PLEX<sup>®</sup> System</strong></p><p>Join Dr. Morgan for a practical workshop showcasing how Cedars Sinai is optimizing syndromic testing with LIAISON PLEX<sup>®</sup> and <em>Flex</em>™ Testing. This session will outline real-world implementation, clinical use cases, and operational drivers behind the shift toward customizable panels. Learn how tailored respiratory testing supports diagnostic stewardship, streamlines workflows, and aligns testing with patient-specific needs. The discussion will include data on assay performance, panel configuration strategies, and examples of customized panels in clinical use. Also, don't miss an introduction to Diasorin's new bloodstream infection portfolio.</p><p><strong>When:</strong> Friday, June 20, 2025</p><p><strong>Time:</strong> 12:00–12:45 p.m.</p><p><strong>Location: </strong><span class="reply__text">South Hall Level 1, Los Angeles Convention Center, 1201 S Figueroa Street, Los Angeles, CA</span></p><p><strong>Speaker: </strong>Margie Morgan, PhD<br><span class="reply__text">Director of Clinical Microbiology, Pathology and Laboratory Medicine at Cedars Sinai Medical Center, Los Angeles, CA</span></p><p>&nbsp;</p> Los Angeles, CA Diasorin diasorin@nomail.com America/Los_Angeles public
  • -

    ADLM Clinical Lab Expo

    Chicago, Illinois | Americas
    Immunodiagnostics
    Molecular diagnostics
    Find out more
    Add to Calendar
    Add to Calendar 2025-07-29T00:00:00 2025-07-31T23:59:59 ADLM Clinical Lab Expo Chicago, Illinois Diasorin diasorin@nomail.com UTC public

All events

CLOSED

June 2024

Pathway to Implement Congenital CMV Screening and Future Legislation - One State’s Progress
Virtual Event | ONLINE
Molecular diagnostics
Find out more
Past event